Kidney Disease Pipeline Review, H1 2013

Kidney Disease Pipeline Review, H1 2013

Global Markets Directs, \'Kidney Disease Pipeline Review, H1 2013\', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kidney Disease.

Kidney Disease Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

A snapshot of the global therapeutic scenario for Kidney Disease.

A review of the Kidney Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Coverage of products based on various stages of development ranging from discovery till registration stages.

A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Coverage of the Kidney Disease pipeline on the basis of route of administration and molecule type.

Key discontinued pipeline projects.

Latest news and deals relating to the products.

Reasons to buy

Identify and understand important and diverse types of therapeutics under development for Kidney Disease.